Inventor
HARTFORD SUZANNE
US8 patents
Patents
8 patentsUS10787647B2Sep 29, 2020
HSD17B13 variants and uses thereof
REGENERON PHARMA10 citations81
US11519004B2Dec 6, 2022
Transcription modulation in animals using CRISPR/Cas systems
REGENERON PHARMA4 citations71
US11485958B2Nov 1, 2022
HSD17B13 variants and uses thereof
REGENERON PHARMA1 citations70
US12529072B2Jan 20, 2026
Transcription modulation in animals using CRISPR/CAS systems
REGENERON PHARMA0 citations61
US11021719B2Jun 1, 2021
Methods and compositions for assessing CRISPER/Cas-mediated disruption or excision and CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo
REGENERON PHARMA1 citations61
US11866794B2Jan 9, 2024
Cas-ready mouse embryonic stem cells and mice and uses thereof
REGENERON PHARMA0 citations59
US11130999B2Sep 28, 2021
Cas-ready mouse embryonic stem cells and mice and uses thereof
REGENERON PHARMA1 citations59
US12010979B2Jun 18, 2024
Non-human animals comprising a humanized TTR locus and methods of use
REGENERON PHARMA0 citations48